StocksTelegraph
S&P 500NASDAQDOWRUSSELL
NASDAQ · HSIC·Healthcare

Henry Schein, Inc. Stock Analysis & AI Score

Market Open
$85.20
Prev Close
Market Cap
Day Range
52W Range
P/E
EPS (TTM)
Volume
Avg —
Beta
49
ST Score
49.2/100C+

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees
CEO
SectorHealthcare
IndustryMedical - Distribution
IPO Date
Website
Country
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

HSIC
49.2out of 100
Grade C+

Henry Schein, Inc. (HSIC) holds an ST Score of 49.2 out of 100 (C+), with its strongest factor being Profitability (A-) and its weakest Valuation (F). Analysts rate HSIC Buy across 34 ratings with a $92.33 average price target (+0.1% vs the current $85.20).

Strongest
ProfitabilityA-
Weakest
ValuationF
All factor grades
  • ProfitabilityA-
  • MomentumB+
  • Financial StrengthC+
  • ForecastC+
  • GrowthC
  • ValuationF
  • Piotroski6/9
Score methodology
Press Releases

Contact

HSIC stock: frequently asked questions

What is HSIC's ST Score?

Henry Schein, Inc. (HSIC) has an ST Score of 49.2 out of 100, an overall grade of C+. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is HSIC a buy, sell, or hold?

Wall Street's consensus rating on HSIC is Buy based on 34 analyst ratings. Our own ST Score grades it C+ (49.2/100). This is data, not investment advice — always do your own research.

What is HSIC's valuation grade?

Henry Schein, Inc. (HSIC) earns a valuation grade of F, measured against Medical - Distribution peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is HSIC's growth grade?

Henry Schein, Inc. (HSIC) earns a growth grade of C, measured against Medical - Distribution peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is HSIC's profitability grade?

Henry Schein, Inc. (HSIC) earns a profitability grade of A-, measured against Medical - Distribution peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is HSIC's financial strength grade?

Henry Schein, Inc. (HSIC) earns a financial strength grade of C+, measured against Medical - Distribution peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for HSIC?

The average analyst price target for Henry Schein, Inc. (HSIC) is $92.33 from 34 analysts, which is +0.1% versus the recent price of $85.20.

What is HSIC's Piotroski score?

Henry Schein, Inc. (HSIC) has a Piotroski F-Score of 6 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.